311690 — CJ Bioscience Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for CJ Bioscience, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	39,255	80,060	49,308	64,095	75,309
Net Total Accounts Receivable
Net Total Receivables	409	721	1,025	540	967
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	41,089	81,555	50,932	65,210	76,762
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19,991	9,856	14,364	12,707	8,907
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	73,362	116,355	91,389	91,128	99,610
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,004	23,836	34,979	14,722	18,525
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	38,878	28,502	41,734	19,633	21,853
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	34,484	87,853	49,655	71,496	77,757
Total Liabilities & Shareholders' Equity	73,362	116,355	91,389	91,128	99,610
Total Common Shares Outstanding